Depomed (DEPO) Analysts See $-0.32 EPS; NGL Energy Partners LP (NGL) Covered By 5 Bullish Analysts Last Week

October 18, 2017 - By Dolores Ford

Among 10 analysts covering NGL ENERGY PARTNERS LP (NYSE:NGL), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. NGL ENERGY PARTNERS LP had 42 analyst reports since August 11, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Friday, January 20 by FBR Capital. The stock of NGL Energy Partners LP (NYSE:NGL) has “Buy” rating given on Wednesday, November 11 by Wunderlich. The company was maintained on Wednesday, November 30 by Stifel Nicolaus. Wells Fargo downgraded the shares of NGL in report on Monday, July 17 to “Market Perform” rating. The stock of NGL Energy Partners LP (NYSE:NGL) has “Buy” rating given on Tuesday, August 25 by Wunderlich. The rating was upgraded by Bank of America on Tuesday, December 6 to “Buy”. The company was upgraded on Thursday, January 12 by Raymond James. The firm has “Equal Weight” rating by Barclays Capital given on Wednesday, November 11. Wunderlich downgraded it to “Hold” rating and $15 target in Monday, January 11 report. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, October 15 report. See NGL Energy Partners LP (NYSE:NGL) latest ratings:

15/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $14.0 Maintain
21/09/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $10.0 Maintain
11/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $14.0 Maintain
16/08/2017 Broker: Stifel Nicolaus Rating: Hold Old Target: $13 New Target: $10 Maintain
04/08/2017 Broker: UBS Rating: Buy Old Target: $18.00 New Target: $14.00 Maintain
04/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $14.0000 Maintain
17/07/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $13.0000 Maintain
17/07/2017 Broker: Wells Fargo Old Rating: Outperform New Rating: Market Perform Downgrade
08/06/2017 Broker: FBR Capital Rating: Mkt Perform Old Target: $22.00 New Target: $19.00 Maintain
29/05/2017 Broker: FBR Capital Rating: Hold Maintain

Analysts expect Depomed Inc (NASDAQ:DEPO) to report $-0.32 EPS on November, 6.They anticipate $0.11 EPS change or 52.38% from last quarter’s $-0.21 EPS. After having $-0.43 EPS previously, Depomed Inc’s analysts see -25.58% EPS growth. The stock increased 2.67% or $0.14 during the last trading session, reaching $5.39. About 1.06M shares traded. Depomed Inc (NASDAQ:DEPO) has declined 46.86% since October 18, 2016 and is downtrending. It has underperformed by 63.56% the S&P500.

Among 14 analysts covering Depomed Inc (NASDAQ:DEPO), 5 have Buy rating, 2 Sell and 7 Hold. Therefore 36% are positive. Depomed Inc had 43 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Tuesday, August 8 by Janney Capital. The firm has “Hold” rating by WallachBeth Capital given on Friday, July 24. The rating was upgraded by WallachBeth Capital on Wednesday, November 11 to “Buy”. The firm has “Hold” rating given on Wednesday, October 11 by Mizuho. The company was downgraded on Monday, December 12 by Piper Jaffray. The firm has “Sector Perform” rating given on Wednesday, October 21 by RBC Capital Markets. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, December 3. On Thursday, March 10 the stock rating was initiated by Leerink Swann with “Outperform”. As per Friday, July 14, the company rating was maintained by RBC Capital Markets. Roth Capital maintained Depomed Inc (NASDAQ:DEPO) rating on Wednesday, November 11. Roth Capital has “Buy” rating and $24 target.

Investors sentiment decreased to 0.87 in Q2 2017. Its down 0.29, from 1.16 in 2017Q1. It fall, as 33 investors sold Depomed Inc shares while 54 reduced holdings. 31 funds opened positions while 45 raised stakes. 54.71 million shares or 0.42% less from 54.94 million shares in 2017Q1 were reported. Amer Incorporated accumulated 43,404 shares or 0% of the stock. Blackrock Inc holds 8.79M shares or 0.01% of its portfolio. Public Sector Pension Invest Board, Quebec – Canada-based fund reported 32,100 shares. Envestnet Asset Inc stated it has 0% of its portfolio in Depomed Inc (NASDAQ:DEPO). Natl Bank Of Montreal Can accumulated 4,820 shares. Wells Fargo And Communications Mn accumulated 170,101 shares or 0% of the stock. Great West Life Assurance Commerce Can accumulated 88,548 shares. Citadel Advsr Ltd Co stated it has 14,704 shares or 0% of all its holdings. Schwab Charles Mgmt has invested 0% of its portfolio in Depomed Inc (NASDAQ:DEPO). Wfg Advsr Limited Partnership reported 280 shares or 0% of all its holdings. California State Teachers Retirement System holds 0% of its portfolio in Depomed Inc (NASDAQ:DEPO) for 101,123 shares. Arizona State Retirement System stated it has 0% in Depomed Inc (NASDAQ:DEPO). Thompson Davis And has invested 0.01% in Depomed Inc (NASDAQ:DEPO). Wellington Shields Lc invested 0.03% in Depomed Inc (NASDAQ:DEPO). Aperio Grp Ltd Liability holds 19,956 shares.

Since May 11, 2017, it had 1 buying transaction, and 3 sales for $3.06 million activity. 15,000 shares valued at $148,800 were bought by HIGGINS ARTHUR J on Monday, June 12. $1.93 million worth of stock was sold by Vargas Thadd M on Tuesday, June 13. Gosling Matthew M had sold 59,212 shares worth $673,300.

Depomed, Inc. is a specialty pharmaceutical company. The company has market cap of $339.51 million. The Firm focuses on pain and other central nervous system conditions. It currently has negative earnings. The Company’s products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), CAMBIA (diclofenac potassium for oral solution), Zipsor (diclofenac potassium) and Lazanda (fentanyl).

NGL Energy Partners LP owns and operates a vertically integrated energy business. The company has market cap of $1.34 billion. The Company’s divisions are crude oil logistics, water solutions, liquids, retail propane, refined products and renewables, and corporate and other. It currently has negative earnings. The Company’s crude oil logistics segment includes owned and leased crude oil storage terminals, and owned and leased pipeline injection stations.

The stock decreased 2.43% or $0.27 during the last trading session, reaching $11.05. About 928,152 shares traded. NGL Energy Partners LP (NYSE:NGL) has risen 16.78% since October 18, 2016 and is uptrending. It has outperformed by 0.08% the S&P500.

Since May 31, 2017, it had 0 insider purchases, and 5 insider sales for $8.26 million activity. Highstar Capital IV – L.P. had sold 95,094 shares worth $1.31M.

Investors sentiment decreased to 1.31 in Q2 2017. Its down 0.26, from 1.57 in 2017Q1. It turned negative, as 17 investors sold NGL Energy Partners LP shares while 25 reduced holdings. 14 funds opened positions while 41 raised stakes. 81.25 million shares or 3.02% less from 83.78 million shares in 2017Q1 were reported. Baldwin Brothers Ma holds 6,250 shares or 0.01% of its portfolio. 2.12 million are owned by State Bank Of Montreal Can. Manufacturers Life The has 0% invested in NGL Energy Partners LP (NYSE:NGL) for 200 shares. Nbw Cap Limited Liability Corporation reported 400,541 shares. Barclays Public Limited Liability Company reported 0% of its portfolio in NGL Energy Partners LP (NYSE:NGL). Benjamin F Edwards And holds 0% in NGL Energy Partners LP (NYSE:NGL) or 2,100 shares. Pnc Gp holds 100,610 shares or 0% of its portfolio. Mariner Wealth Ltd Limited Liability Company holds 11,225 shares or 0.01% of its portfolio. Goldman Sachs Grp has 3.07M shares. Citadel Limited Liability holds 0% or 25,000 shares in its portfolio. 121,003 are owned by Highland Cap Management Lp. Toronto Dominion Commercial Bank has invested 0% in NGL Energy Partners LP (NYSE:NGL). Hsbc Holdg Public Limited Company owns 44,000 shares or 0% of their US portfolio. Walleye Trading Limited Liability Com has 0% invested in NGL Energy Partners LP (NYSE:NGL). Davenport Lc accumulated 0% or 22,050 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com